155 related articles for article (PubMed ID: 38560429)
1. A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer.
Nishioka K; Hashimoto T; Mori T; Uchinami Y; Kinoshita R; Katoh N; Taguchi H; Yasuda K; Ito YM; Takao S; Tamura M; Matsuura T; Shimizu S; Shirato H; Aoyama H
Adv Radiat Oncol; 2024 May; 9(5):101464. PubMed ID: 38560429
[TBL] [Abstract][Full Text] [Related]
2. A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size.
Shimizu S; Miyamoto N; Matsuura T; Fujii Y; Umezawa M; Umegaki K; Hiramoto K; Shirato H
PLoS One; 2014; 9(4):e94971. PubMed ID: 24747601
[TBL] [Abstract][Full Text] [Related]
3. Analysis of treatment process time for real-time-image gated-spot-scanning proton-beam therapy (RGPT) system.
Yoshimura T; Shimizu S; Hashimoto T; Nishioka K; Katoh N; Inoue T; Taguchi H; Yasuda K; Matsuura T; Takao S; Tamura M; Ito YM; Matsuo Y; Tamura H; Horita K; Umegaki K; Shirato H
J Appl Clin Med Phys; 2020 Feb; 21(2):38-49. PubMed ID: 31886616
[TBL] [Abstract][Full Text] [Related]
4. Real-Time Gated Proton Therapy: Commissioning and Clinical Workflow for the Hitachi System.
Chen H; Gogineni E; Cao Y; Wong J; Deville C; Li H
Int J Part Ther; 2024 Mar; 11():100001. PubMed ID: 38757076
[TBL] [Abstract][Full Text] [Related]
5. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.
Kupelian PA; Reddy CA; Carlson TP; Altsman KA; Willoughby TR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):904-12. PubMed ID: 12095556
[TBL] [Abstract][Full Text] [Related]
6. Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation study.
Matsuura T; Maeda K; Sutherland K; Takayanagi T; Shimizu S; Takao S; Miyamoto N; Nihongi H; Toramatsu C; Nagamine Y; Fujimoto R; Suzuki R; Ishikawa M; Umegaki K; Shirato H
Med Phys; 2012 Sep; 39(9):5584-91. PubMed ID: 22957624
[TBL] [Abstract][Full Text] [Related]
7. A dose escalated fiducial marker-based image guided radical radiotherapy in locally advanced prostate cancers: A single institute experience from India.
Gupta PK; Rastogi N; Maria Das KJ; Kumar S
J Cancer Res Ther; 2023; 19(2):382-388. PubMed ID: 37006073
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of treatments using real-time image gated spot-scanning with synchrotron-based proton beam therapy system log data.
Yoshimura T; Shimizu S; Hashimoto T; Nishioka K; Katoh N; Taguchi H; Yasuda K; Matsuura T; Takao S; Tamura M; Tanaka S; Ito YM; Matsuo Y; Tamura H; Horita K; Umegaki K; Shirato H
J Appl Clin Med Phys; 2020 Dec; 21(12):10-19. PubMed ID: 33151643
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a short-range applicator for treating superficial moving tumors with respiratory-gated spot-scanning proton therapy using real-time image guidance.
Matsuura T; Fujii Y; Takao S; Yamada T; Matsuzaki Y; Miyamoto N; Takayanagi T; Fujitaka S; Shimizu S; Shirato H; Umegaki K
Phys Med Biol; 2016 Feb; 61(4):1515-31. PubMed ID: 26815927
[TBL] [Abstract][Full Text] [Related]
10. Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study.
Li P; Hong Z; Li Y; Fu S; Zhang Q
Front Oncol; 2021; 11():808216. PubMed ID: 35223457
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.
Takeda K; Takai Y; Narazaki K; Mitsuya M; Umezawa R; Kadoya N; Fujita Y; Sugawara T; Kubozono M; Shimizu E; Abe K; Shirata Y; Ishikawa Y; Yamamoto T; Kozumi M; Dobashi S; Matsushita H; Chida K; Ishidoya S; Arai Y; Jingu K; Yamada S
Radiat Oncol; 2012 Jul; 7():105. PubMed ID: 22770471
[TBL] [Abstract][Full Text] [Related]
12. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.
Quon H; Cheung PC; Loblaw DA; Morton G; Pang G; Szumacher E; Danjoux C; Choo R; Thomas G; Kiss A; Mamedov A; Deabreu A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):898-905. PubMed ID: 21237581
[TBL] [Abstract][Full Text] [Related]
14. Validation of dose distribution for liver tumors treated with real-time-image gated spot-scanning proton therapy by log data based dose reconstruction.
Yamada T; Takao S; Koyano H; Nihongi H; Fujii Y; Hirayama S; Miyamoto N; Matsuura T; Umegaki K; Katoh N; Yokota I; Shirato H; Shimizu S
J Radiat Res; 2021 Jul; 62(4):626-633. PubMed ID: 33948661
[TBL] [Abstract][Full Text] [Related]
15. Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002.
Vargas CE; Hartsell WF; Dunn M; Keole SR; Doh L; Chang J; Larson GL
Rep Pract Oncol Radiother; 2016; 21(3):207-12. PubMed ID: 27601952
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.
Bryant C; Smith TL; Henderson RH; Hoppe BS; Mendenhall WM; Nichols RC; Morris CG; Williams CR; Su Z; Li Z; Lee D; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):422-434. PubMed ID: 27084658
[TBL] [Abstract][Full Text] [Related]
17. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.
Yeoh EE; Fraser RJ; McGowan RE; Botten RJ; Di Matteo AC; Roos DE; Penniment MG; Borg MF
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):943-55. PubMed ID: 12605972
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 Weeks.
Nakamura K; Ikeda I; Inokuchi H; Aizawa R; Ogata T; Akamatsu S; Kobayashi T; Mizowaki T
Pract Radiat Oncol; 2023; 13(6):e530-e537. PubMed ID: 37414247
[TBL] [Abstract][Full Text] [Related]
19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
20. Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.
Kupelian PA; Reddy CA; Klein EA; Willoughby TR
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):988-93. PubMed ID: 11704322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
